Skip to main content

Advertisement

Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial

Fig. 2

HbA1c levels in participants receiving LM25 or IGL. Observed HbA1c levels at baseline, week 12, and week 24 in participants receiving LM25 or IGL. Values in boxes denote mean HbA1c. HbA1c glycated hemoglobin, IGL once-daily basal insulin glargine plus once-daily prandial insulin lispro, LM25 75 % insulin lispro protamine suspension and 25 % insulin lispro solution

Back to article page